Total Funding
94
84
Total FundingGrant raised
Growth Score 94 in past quarter
9 pts
Heat Score 84 in past quarter
40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4444
Sonire Therapeutics is a medical equipment manufacturing company that develops a device for ultrasound treatment system.
- Shin Yoshizawa: CTO
- Naoki Kobayashi: CFOPast Role: Modalis Therapeutics, CFO
About the Company
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel
therapeutic modality with the goal of giving cancer patients and their families a new future.